Traditional Chinese medicine composition for treating hepatitis B

Abstract

The invention discloses a traditional Chinese medicine composition for treating hepatitis B, which is characterized in that the active ingredients are prepared from the following raw materials in parts by weight: 5-15 parts of snow of June herb, 10-20 parts of radix aucklandiae, 5-10 parts of fructus aurantii immaturus, 8-15 parts of cornu saigae tataricae powder, 6-18 parts of cortex moutan, 15-20 parts of cyrtomium rhizome, 2-10 parts of pericarpium arecae, 8-20 parts of longhairy antenoron herb, 10-30 parts of ixeris herba, 10-20 parts of radix morindae officinalis, 10-15 parts of radix astragali, 5-15 parts of radish seed, 10-20 parts of fructus schisandrae, 10-20 parts of herba verbenae and 4-16 parts of lucid ganoderma. The traditional Chinese medicine composition for treating hepatitis B, which is disclosed by the invention, has the functions of clearing heat, promoting diuresis, removing toxin, eliminating yellow, resolving stasis, dredging all channels, nourishing kidney and liver, regulating qi and blood and promoting qi to activate blood, and realizes remarkable treatment on hepatitis B.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating hepatitis B, in particular to a Chinese medicinal composition prepared from Chinese herbal medicines for treating hepatitis B. Background technique [0002] Hepatitis B virus, referred to as hepatitis B, is a disease caused by the hepatitis B virus (HBV) after infecting the body. Hepatitis B virus is a hepatotropic virus that mainly exists in liver cells and damages liver cells, causing inflammation, necrosis, and fibrosis of liver cells. There are two types of hepatitis B: acute and chronic. Acute hepatitis B can be cured by itself in 90% of adults, while chronic hepatitis B has different manifestations, including chronic hepatitis B carriers, chronic active hepatitis B, and hepatitis B cirrhosis. my country's current hepatitis B virus carrier rate is 7.18%, which is the country with the highest hepatitis B infection rate in the world. About one-third of them had recurrent liver...

AI Technical Summary

Problems solved by technology

Most of the methods for clinical treatment of hepatitis B are anti-fibrosis treatment of hepatitis B, antiviral drugs such as immunomodulators, and the therapeutic effect is often not ideal

Although traditional Chinese medicine preparations are more and more favored by patients, they have the disadvantages of inaccurate curative effect and poor treatment effect, which bring double harm to patients both physically and mentally.